William Mir
About William Mir
William Mir is the Director of US Marketing for CAR T at Bristol Myers Squibb, with over 15 years of experience in the pharmaceutical and biotechnology industries, specializing in oncology marketing.
Title
William Mir is the Director of US Marketing for CAR T at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
William Mir currently holds the position of Director of US Marketing, CAR T at Bristol Myers Squibb in Seattle, Washington. His role involves leading the marketing strategy for Breyanzi, a CAR T cell therapy.
Previous Positions in Oncology Marketing
Prior to his current role, William Mir served as Associate Director of Oncology Marketing - CAR T at Juno Therapeutics, Inc. from 2018 to 2021. Before that, he worked at Amgen where he held various positions including Sr. Marketing Manager for both Value & Access and Neulasta, as well as Oncology Product Manager, Franchise Marketing - REMS Lead & GPO Liaison.
Professional Experience in Pharmaceutical Sales
William Mir's extensive experience in pharmaceutical sales includes roles at Amgen as Sr. Biopharmaceutical Representative in both the Bone Health and Nephrology Business Units. He also worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Professional Sales Representative for the Central Nervous System division.
Early Career and Transition to Pharmaceuticals
William Mir began his career at State Farm as a Life/Fire Underwriter, a position he held for six years. He subsequently transitioned to the pharmaceutical industry, leveraging his skills in sales and marketing.
Education and Expertise
William Mir earned his Master of Business Administration (MBA) from the University of Southern California from 2010 to 2012. He has over 15 years of experience in the pharmaceutical and biotechnology industries, specializing in oncology marketing with a focus on CAR T cell therapies.